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Abstract
Background: The present study compared the differences between survivals of patients with colorectal cancer
according to their ethnicity adjusted for other predictors of survival.
Methods: In this prospective cohort study patients were followed up from definite diagnosis of colorectal can-
cer to death. Totally, 2431 person-year follow-ups were undertaken for 1127 colorectal cancer patients once
every six months. The data were analyzed by stata software using bivariate analysis, multivariate analysis, and
Cox regression.
Results: The age at diagnosis was significantly different between men and women (p<0.03). 61.2% were male
and the rest were female. Most patients were Fars (51.2%), followed by Turciks (21.5%), Kurds (8.2%), and
7.5% Lurs. Of the patients, 75% had a survival of more than 2.72 years, 50% a survival of 5.83 years, and 25%
longer than 13.1 years after diagnosis. Risk ratio was significantly different among ethnics (p<0.05). The varia-
bles of ethnicity, being non married, tumor grade, family history of cancer, and smoking were considered as
determinants of the patients’ survival in Cox regression model. The median survival time in Fars, Kurds, Lurs,
Turks and other ethnics was 5.83, 2.44, 5.49, and 8.52 years, respectively.
Conclusion: Ethnicity and access to healthcare are predictors of survival of patients with colorectal cancer
which may define priorities in controlling cancer and implementing interventional and prevention plans.
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Introduction
Colorectal cancer (CRC) is one of the
most important reasons for death world-
wide. It is the third leading cancer resulting
in death in western countries (1). Racial-
ethnic disparities are well known for influ-
encing CRC outcomes. The global burden
of cancers is increasing. The survival of the
sufferers in developing countries is less
compared to developed countries. In devel-
oping countries, cancer is diagnosed at late
stages and access to standard diagnostic
and therapeutic services is limited (2). CRC
is the third prevalent cancer among men
and the second prevalent cancer among
women. In 2008, more than 1.2 million new
cases of CRC and 608700 deaths due to
CRC were reported (1-3). CRC is also the
second cancer leading to death in the Unit-
ed States. Although CRC-associated deaths
are declining in the United States, racial
and ethnic disparities exist in its outcomes.
One of the reasons is that ethnic minorities
are less willing to undergo CRC screening
(4). Low socioeconomic status is also in-
versely associated with increase in the risk
of CRC occurrence. The risk of CRC in
low socioeconomic classes is 30% higher
compared to high socioeconomic classes
(5). The increase in CRC prevalence is rap-
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idly growing in the countries with western
culture (6). CRC occurrence is mainly ob-
served in the population above 55 years
old. The occurrence is different among dif-
ferent populations and is decreasing in the
United States (7,8). There is some hidden
or constant increase in CRC in Europe.
CRC is also on increase in Asian countries
(9). Ethnic and/or racial disparities appear
to influence CRC occurrence in many
countries including the United States, New
Zealand, and Australia (between natives
and non-natives, and blacks and whites)
(8,10-13). Iran is also a multi-ethnic coun-
try. Different access rate to diagnostic and
therapeutic services play the most im-
portant role in ethnic CRC disparities
(10,14). Regarding lack of report on surviv-
al time for CRC in Iranian societies we
conducted the present study to compare the
survival rate in the patients with CRC ac-
cording to their ethnicity. The present study
compares the differences of survival of pa-
tients with colorectal cancer according to
their ethnicity adjusted for other predictors
of survival in these patients.
Methods
The present study was a prospective, co-
hort one. Data were obtained from Cancer
Registry Center of the Research Institute of
Gastroenterology and Liver Disease
(RIGLD) affiliated to Shaheed Beheshti
University of Medical Sciences, Tehran,
Iran. The time period of the study was
specified from 2008 to 2012.  The patients
from public and private collaborative hos-
pitals were treated and referred to the can-
cer registry. This study was based on the
data derived from cancer registry forms in-
cluding demographic variables, family his-
tory, and diagnosis. All patients with CRC
diagnosis based on the pathology report of
cancer registry were eligible for this study.
Each participant was interviewed by a phy-
sician who performed a physical examina-
tion and obtained a detailed medical histo-
ry. The data were recorded meticulously.
The outcome in question was survival time
of the patients from the time of diagnosis.
The main exposure in question was the pa-
tients’ ethnic which was measured by ques-
tionnaire and categorized into five catego-
ries (Fars, Turks, Kurds, Lurs, and others).
To evaluate other prognostic factors of sur-
vival we also entered the following varia-
bles in the model: tumor stage according to
tumor, node, metastases (TNM) index (ad-
vanced stage versus early stage), tumor
grade (grade III to IV, grade II versus grade
I), marital status (married versus non mar-
ried), gender (female versus male), educa-
tion (university degree, high school, prima-
ry school versus illiterate), age group
(>65years, 45-65 years, versus<45 years),
family history of cancer (yes versus no),
and current  smoking  situation (smoking
versus nonsmoking). CRC diagnosis was
done according to the criteria of Interna-
tional Classification of Diseases and Pa-
thologies and US Commission on Cancer’s
Report of Pathology and Criteria.
This study held Shaheed Beheshti Uni-
versity of Medical Sciences Ethics Com-
mittee’s approval no. 676. All the patients
signed an informed consent before taking
part in the study. All the patients were fol-
lowed up from the time of diagnosis until
death or completion of study time. Final
outcome was asked by telephone call dur-
ing each 6 months through follow-up.  Re-
sponse rate was very good and 98% of pa-
tients were followed up. Descriptive indi-
ces, occurrence rate were calculated and
univariate analyses were performed. Cox
regression model was used to assess the
effect of ethnicity on survival adjusted for
other prognostic variables. Proportional
hazards assumption was evaluated by
measuring Schoenfeld residuals for the var-
iables entered into the model. P value less
than 0.05 was considered as the level of
significance. All the analyses were per-
formed using Stata software version 12.
Results
Totally, 2431 person-year follow-ups
were performed for 1127 patients with
CRC. Of 1127 patients with CRC, 690
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(61.2%) were male and 437 were female.
Their age range was 14-94 years old. Mean
(SD) of age at the time of CRC diagnosis
was 53.5 (14) years. Of the patients, 30.2%
were under 45 years old, 45.5% were 45-65
years old, and 24.3% were older than 65
years old. Most patients (45.5 %) were at
45-65 years age group. The mean age at
diagnosis was 54.3 years for men and 52.4
years for women. The difference was statis-
tically, but not practically, significant (p<
0.03). Most patients were Fars (51.2%),
followed by Turciks (21.5%), Kurds
(8.2%), Lurs (7.5%), and other ethnics
(consisting of Balouch, Gilaki, Mazani, Ar-
ab, and Afghan (10.8%)).
Table 1 shows the demographic charac-
teristics of the population under study and
also the basic statistics about the outcome
in different subgroups of demographic
characteristics and clinical stages of the pa-
tients. Of the patients, 75% had survival of
more than 13.1 years, 50% survival of 5.84
years, and 25% survival of longer than 13
years after diagnosis. Among the ethnics,
Kurds had the highest incidence rate of
mortality (IRM) (103.7) and Turks the low-
est (70.8). Hazard ratio was significantly
different among different ethnics (p< 0.05).
The variables of ethnicity, being non mar-
ried, cancer grade, family history of cancer,
and smoking were considered as determi-
nants of the patients’ survival in Cox re-
gression model. The median survival time
in Fars, Kurds, Lurs, Turks, other ethnics,
and all of the patients was respectively
5.83, 2.44, 5.49, 8.52, and 3.72 years.
Results of univariate and multivariate
Cox regression analysis for estimating the
hazard of ethnicity adjusted for demograph-
ic and clinical characteristics on mortality
of CRC patients are presented in Table 2.
Discussion
Conventionally, a group of people with
similar or common ancestral and familial
characteristics is called ethnicity. Ethnic
groups hold cultural, lingual, behavioral,
and religious commonalities which may go
back to their ancestors and/or could emerge
for other reasons. Therefore, an ethnic
group could be a cultural community as
Table 1. Demographic and clinical characteristics of population under study and 3/5 year mortality rate in demographic
and clinical subgroups of patients
Characteristic No. (%) Death (No.) IRM * (per 1000) IRM (95% CI)
Ethnicity Fars
Kurd
Lur
Turcik
Others **
52
8.2
7.5
21.5
10.8
120
15
16
38
46
94.5
103.7
88.7
70.8
153
79 – 113.1
62.4 – 171.9
54.3 – 144.8
51.5 – 97.3
114.6– 204.2
Age Group < 45
45-65
> 65
30.2
45.5
24.3
73
99
63
89
83
111
70.8 – 112
68.6 – 101
87 - 142
Sex Male
female
61.3
38.7
150
85
96.9
83
82.9 – 113.8
67.1 – 102.7
Marital status Married
non married
93
7
197
24
85.3
161
74.2 – 98.1
107.9 –240.3
Education illiterate
primary school
high school
university
26.5
32.2
24.5
16.8
56
49
35
31
113
79.8
76.2
80
86.9 – 146.8
60.3 – 105.5
54.7 – 106.1
56.3 – 113.9
Tumor grade grade I
grade II
grades III to IV
55.5
35.7
8.8
66
63
20
66.1
98.6
123.7
51.8 – 84
77 – 126
79 - 191
Stage early stage
advanced stage
45.2
54.8
76
124
70.6
109.8
56.4 – 88.4
92 - 131
Family history of can-
cer
No
Yes
63.2
36.8
145
79
99
78
84 – 116
62 - 97
Smoking No
Yes
73.5
26.5
150
65
86.8
101.5
64-101.9
79.6-129.5
* Incidence rate of mortality, ** Others: Balouch, Gilaki, Mazani, Arab, and Afghan.
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well. In slavery and feudal societies, ethnic-
ity is referred to a kind of commonality
among people with blood ties, shared land,
language, and culture; however, this com-
monality is not firm enough and, in national
scale, the economic commonalities are not
still complete. Iran’s nation consists of dif-
ferent ethnics including Fars (53%),
Azarbaijanis (16%), Kurds (10%), Gilakis
and Mazanis (7%), Lurs (6%), Balouch
(2%), Arabs (2%), Turkmens and Qashqais
(2%), and others (2%). Ethnicity is used as
an important underlying variable in exam-
ining health and equality of accessing
healthcare and treatment services (25-27).
Ethnicity could represent a genetic factor,
environmental exposure, and nutritional
habits of a particular ethnic group in a re-
gion. Study of diseases in different ethnics
could help in identifying genetic and envi-
ronmental reasons for disease, the differ-
ence in diseases’ burden, and the interven-
tions undertaken for reducing this differ-
ence in society (27). In the present study, a
disparity was observed in CRC-associated
risk ratio among Iranian ethnics. In Iran
diagnostic, healthcare, and therapeutic ser-
vices for CRC have been concentrated in
Tehran and other major cities, which is dif-
ferent from smaller cities and settlements of
ethnic minorities.
This research is the first conducted on the
role of ethnicity in survival after colorectal
carcinomas in Iranian population. Compari-
son among Iranian ethnics indicated that
Kurds had the minimum survival and Turks
had the maximum survival following colo-
rectal carcinoma. In Cox regression model,
risk ratio despite other variables and con-
trolling for confounding factors was ob-
tained as 1.95 for Kurds, which was signif-
icant (p=0.046). It was obtained as 0.44 for
Lurs, which was the lowest in the model.
The third grade of cancer, family history of
cancer occurrence, and smoking were sig-
nificant variables (p<0.05) in Cox regres-
sion model. Our results are consistent with
those of studies that reported disparities in
occurrence rate of cancer in Hispanic
whites and non-Hispanic populations in the
United States (1,8). In the present study,
CRC and its associated mortalities were
strongly and inversely associated with the
level of education and literacy.  CRC Sur-
vival in illiterate patients was lower com-
pared to the literate. This is also consistent
with studies conducted in other countries
(5,11). Therefore, the illiterate people
should be given priority in interventions,
control, and prevention plans developed for
Table 2. Results of univariate and multivariate cox regression analysis for estimating the hazard of ethnicity adjusted for
demographic and clinical characteristics on mortality of CRC patients
Characteristic Univariate Analysis:
HR (95% CI)
Multivariate Cox model
Hazard Ratio SE P-Value 95%  CI
Ethnicity Fars
Kurd
Lur
Turcik
Others *
-
1.1 : 0.6-1.8
0.9 : 0.5 – 1.6
0.7 : 0.5 – 1.1
1.6 : 1.1 -2.3
-
1.95
0.44
0.59
1.44
-
0.65
0.19
0.17
0.45
-
0.046
0.071
0.071
0.234
-
1.01 – 3.76
0.18 – 1.07
0.33 – 1.04
0.78 – 2.67
Marital status Married
non married
-
1.8 : 1.2 – 2.8
-
2.14
-
0.63
-
0.010
-
1.19 – 3.84
Education Illiterate
Primary school
High school
University
1.4: 0.9 -2.1
0.9 : 0.6 -1.5
0.9 : 0.5 -1.5
-
1.54
0.93
0.94
-
0.43
0.26
0.99
-
0.12
0.806
0.849
-
0.89 – 2.68
0.53 – 1.63
0.51 – 1.72
-
Tumor grade grade I
grade II
grades III to IV
-
1.4 : 1.1 -2.1
1.8 : 1.1-3.1
-
1.21
2.11
-
0.26
0.61
-
0.372
0.010
-
0.79 – 1.86
1.19 – 3.75
Age of Diagnosis 1.2 : 0.9 – 1.7 1.004 0.07 0.611 0.98 – 1.01
Family history No
Yes
-
0.7 : 0.6 – 1.1
-
0.58
-
0.12
-
0.014
-
0.38 – 0.89
Smoking No
Yes
-
1.1 : 0.8 – 1.5
-
1.55
-
0.32
-
0.036
-
1.03 – 2.34
* Others: Balouch, Gilaki, Mazani, Arab, and Afghan.
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CRC. The stage or grade of CRC at diagno-
sis was an important and significant varia-
ble in the model, which is consistent with
another study (12). CRC-associated mortal-
ities were higher in above 65-year-old pa-
tients compared to the other age groups.
There was no significant difference in sur-
vival between the two genders. However,
the age at diagnosis was two years lower
for women compared to men. This finding
probably is in agreement with other studies
reporting that women follow healthcare
more and have higher rate of participation
in screening plans compared to men (15-
19). In the present study, smoking in-
creased the risk of death in the patients,
which is consistent with a study in the
United States that reported smoking in-
creased mortality risk after CRC diagnosis
(20). In this study, positive family history
was not a significant risk factor for increase
in death and decrease in survival. In several
studies, positive family history has been
offered as a factor for screening CRC.
However, a study conducted in Germany
reported that smoking and being male are
more effective on CRC compared to family
history, (21) that is consistent with our
study. The median of survival time after
CRC treatment was 4-13 months in the pre-
sent study and 15.4 months in a study con-
ducted in the United States (22). In our
study, survival of the married was higher
than that of non-married, which is in
agreement with similar studies (23,24). In
the present study, the demographic deter-
minants of the patients’ survival are con-
sistent with similar studies. Risk ratio for
CRC death has been reported in terms of
ethnicity.
Conclusion
Therefore, through determining the
above-mentioned variables, policy makers
and planners of health system could pay
more attention to access to and quality of
the diagnostic and therapeutic services in
Iranian ethnics and promotion of these ser-
vices in the ethnics with shorter survival
time, and hence decrease the disparity in
the patients’ survival in different ethnics.
Relevant studies in national scale are rec-
ommended to determine genetic or envi-
ronmental reasons for the disease including
nutritional regime and cultural and behav-
ioral habits in different ethnics to establish
the reasons for the difference in CRC sur-
vival among the ethnics. Socioeconomic
status, ethnicity, and access to health care
may explain major ethnic disparities in
CRC patients. Addressing priorities in con-
trolling cancer and implementing interven-
tional and prevention plans is recommend-
ed.
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